Arax Advisory Partners’s Boston Scientific BSX Stock Holding History

Arax Advisory Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3M	Buy	77,337 +59,460	+333%	+$3.23M	0.02%	623
2026 Q1	$1.12M	Buy	17,877 +4,215	+31%	+$337K	0.03%	403
2025 Q4	$1.3M	Sell	13,662 -24,815	-64%	-$2.43M	0.04%	322
2025 Q3	$3.76M	Buy	38,477 +35,211	+1,078%	+$3.65M	0.05%	300
2025 Q2	$410K	Buy	3,266 +1,607	+97%	+$163K	0.02%	446
2025 Q1	$167K	Sell	1,659 -142	-8%	-$14.3K	0.01%	579
2024 Q4	$161K	Buy	1,801 +1,130	+168%	+$99.5K	0.01%	545
2024 Q3	$56.2K	Buy	671 +139	+26%	+$11K	0.01%	673
2024 Q2	$41K	Buy	+532	New	+$38.9K	﹤0.01%	732
2020 Q4	$1K	Buy	+32	New	+$1.15K	﹤0.01%	692
2018 Q3	–	Sell	-132	Closed	-$4K	–	633
2018 Q2	$4K	Buy	132 +65	+97%	+$1.96K	﹤0.01%	395
2018 Q1	$1K	Buy	+67	New	+$1.82K	﹤0.01%	443

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Arax Advisory Partners's BSX Position: Q2 2026 in Review

Arax Advisory Partners increased its Boston Scientific (BSX) stake by 333% in Q2 2026, buying an estimated $3.23M and bringing the position to 77,337 shares worth $3.3M. The position accounts for 0.02% of the portfolio, ranked #623.

Arax Advisory Partners first reported a position in BSX in Q1 2018 and has held it in 12 quarters since. The position peaked at $3.76M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Arax Advisory Partners held 77,337 shares of Boston Scientific worth $3.3M as of Q2 2026.
Arax Advisory Partners bought 59,460 Boston Scientific shares in Q2 2026, an estimated $3.23M.
Boston Scientific made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #623 holding.
Arax Advisory Partners first reported a position in Boston Scientific in Q1 2018 and has held it in 12 quarters since.
Arax Advisory Partners's Boston Scientific position peaked at $3.76M in Q3 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.